A randomized controlled pilot study of daily intravenous ketamine over three days for treatment-resistant depression by Keerati Pattanaseri, Juthawadee Lortrakul, Kankamol Jaisin, Maytinee Srifuengfung, Naratip Sa-nguanpanich, Natee Viravan, Pornjira Pariwatcharakul, Wattanan Makarasara, Woraphat Ratta-apha

Get full text